Investing.com - J&J (NYSE:JNJ) reported third quarter earnings that beat analyst's expectations on Tuesday and revenue that topped forecasts.
The firm reported earnings per share of $2.05 on revenue of $20.35B. Analysts polled by Investing.com expected EPS of $2.03 on revenue of $20.04B. That compared to EPS of $1.9 on revenue of $19.65B in the same period a year earlier The company had reported EPS of $2.1 on revenue of $20.83B in the previous quarter.
J&J shares slightly moved 0.06% to trade at $133.95 in pre-market trade following the report.
For the year, J&J shares are down 4.09%, under-performing the S&P 500 which is up 2.5% year to date.
J&J follows other major Healthcare sector earnings this month
On Thursday, September 27, 2018, Cantel Medical reported fourth quarter EPS of $0.62 on revenue of $228.85M, compared to forecasts of EPS of $0.58 on revenue of $225.98M.
Neogen earnings matched analyst's expectations on Tuesday, September 25, 2018, with first quarter EPS of $0.29 on revenue of $99.63M. Investing.com analysts expected EPS of $0.29 on revenue of $104.57M
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar